Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

Respiree gets FDA clearance for cardio-respiratory wearable

March 9, 2023 Medical Communications

Respiree, a digital therapeutics start-up, has secured the 510(k) FDA clearance for its RS001 cardio-respiratory wearable.   RS001 is a …
News

Abbott’s concussion-detecting blood test approved by FDA

March 8, 2023 Medical Communications

US-based Abbott, a medical technology company, has received FDA approval for its laboratory blood test which detects traumatic brain injury …
News

Hospital for Special Surgery reveals 3D surface topographic scan for scoliosis patients

March 8, 2023 Medical Communications

Researchers at New York City’s Hospital for Special Surgery (HSS) have found that using a 30-camera array, or 3dMD, can …
News

FDA grants de novo approval to Neuromod’s tinnitus device

March 8, 2023 Medical Communications

The FDA has granted de novo approval to Neuromod’s Lenire device which includes Bluetooth headphones, a handheld controller and the …
News

BioMarin receives FDA update for gene therapy for adults with severe haemophilia A

March 7, 2023 Medical Communications

Global biotechnology company BioMarin Pharmaceutical has announced that it’s received an update from the FDA, detailing the extension of their …
News

Sooma receives FDA Breakthrough Device designation for depression therapy device

March 7, 2023 Medical Communications

Finnish company Sooma Medical has received Breakthrough Device designation by the FDA for its portable, at-home neuromodulation device to treat …
News

Bristol Myers Squibb and Viz.ai sign multi-year partnership for HCM device

March 6, 2023 Medical Communications

Bristol Myers Squibb and Viz.ai, an AI-powered medical imaging company, have signed a deal to use AI to detect and …
News

Elon Musk’s Neuralink rejected by FDA for human trials

March 3, 2023 Medical Communications

The FDA has reportedly rejected a bid by Elon Musk’s Neuralink in which they proposed the initiation of human testing …
News

FDA grants orphan drug designation to Temferon for glioblastoma multiforme

March 3, 2023 Medical Communications

The FDA has granted Temferon an Orphan Drug Designation (ODD) for use as a therapeutic option for patients with glioblastoma …
News

A gene test could guide decisions around chemotherapy for bowel cancer

March 3, 2023 Medical Communications

Scientists from the Institute of Cancer Research London, Imperial College London and the Netherlands Cancer Institute have researched a gene …
News

Microba Life Sciences launches next-generation healthcare testing for gastrointestinal health

March 2, 2023 Medical Communications

Australian precision microbiome company Microba Life Sciences has launched its next-generation testing range for gastrointestinal health. MetaXplore has been relaunched …
News

Eli Lilly caps consumer insulin costs at $35

March 2, 2023 Medical Communications

Eli Lilly & Co has announced that it will cap out-of-pocket insulin costs at $35 per month, following a plea …
News

FDA panel backs GSK RSV vaccine ahead of approval

March 2, 2023 Medical Communications

Yesterday, GSK shared that an advisory committee from the FDA voted in support of its respiratory syncytial virus (RSV) vaccine …
News

NICE recommends more digital mental health therapies for NHS use

March 1, 2023 Medical Communications

Eight more digital therapies (DTx) for mental health disorders have been recommended by NICE for use by the NHS, following …
News

FDA approves Reata Pharmaceuticals’ first-in-class treatment for Friedreich’s Ataxia

March 1, 2023 Medical Communications

US-based Reata Pharmaceuticals has announced that its first-in-class treatment for Friedreich’s Ataxia (FA), Skyclarys, has been given FDA approval. This …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026